Approval · Notice of Compliance 36586 · 2025
TAPAZOLE: Notice of Compliance 36586
Issued December 19, 2025
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 36586
- Date
- December 19, 2025
- Company
- Knight Therapeutics Inc.Montreal, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Administrative: Change in product ownership
Products in this notice
Medicinal ingredients
- METHIMAZOLE 5 MG per TAB
- METHIMAZOLE 10 MG per TAB